Vertex Pharmaceuticals
VRTX
NASDAQ
IPO1991
about VRTX
Vertex Pharmaceuticals is a biotechnology company dedicated to developing life-saving medicines, particularly for cystic fibrosis and other rare diseases, by targeting the underlying genetic causes rather than just symptoms.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $418.00 | $421.94 | $417.37 | $107.73B | 269.79K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$4.02 | n/a | 36.65 | 38.83% | 34.84% | 0% |